Role of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer Patients
Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to:
- evaluate the activity of SAMITAL in reducing the incidence of severe mucositis in
head-and-neck cancer patients undergoing chemo-radiotherapy.
- assess tolerability of SAMITAL and the impact on patients reported outcomes.